InsidersTradesSigma
Follow the Vicore Pharma Holding AB share price and the full directors' dealings record of the company, a listed equity based in Finland. Shares trade on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Vicore Pharma Holding AB has published 5 insider filings. Market capitalisation: €3.1bn. The latest transaction was disclosed on 8 July 2026 (Purchase). Among the most active insiders: Yasir Al-Wakeel. All data is free.
5
Insider Decl.
n/a
Thresholds
€176,070
5 ops.
Buy Volume
n/a
n/a
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Vicore Pharma Holding AB Strong Buy (bullish), based on 5 analysts. Average price target: SEK 31.40.
33Σ signal
Fundamental score
Ranked 22,064 of 28,753 companies
33.2
score / 100
Value14
Quality53
FCF yld-12%
Earn yld-15%
EV/EBITDA·
ROE-47%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 8 July 2026
Declarations5 total
363 shares@ €13.78990.0015% mcap100.0% of flowDepåbevisISIN US92581R1041FI:csv-bbd56d68340298b4cd4c
3 shares@ €13.900.0000% mcap100.0% of flowDepåbevisISIN US92581R1041FI:csv-5d0997c4ef5a13bdfb2e
670 shares@ €14.900.0031% mcap100.0% of flowDepåbevisISIN US92581R1041FI:csv-90937ac96d34791f19f3
160,220 shares@ SEK 10.56030.0051% mcap100.0% of flowAktieISIN SE0007577895FI:csv-0c7f17d1fd70b47c327b
10,000 shares@ €0.70370.0002% mcap100.0% of flowAktieISIN SE0007577895FI:A003O165-1
5 of 5 declarations
About Vicore Pharma Holding AB
Vicore Pharma Holding AB is a biopharmaceutical company focused on developing treatments for respiratory diseases. It is listed on the Stockholm Stock Exchange (XSTO).